Compound ID | 769
VRC 4219
Class: Protein synthesis inhibitor
| Spectrum of activity: | Gram-positive & Gram-negative |
| Details of activity: | Betacin analogue |
| Institute where first reported: | Veriscor (Pfizer, USA) |
| Year first mentioned: | 2001 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| Reason Dropped: | Likely due to Vicuron's programs being dropped by Pfizer after acquiring -(LS) |
| External links: | |
| Citation: |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.